Publications by authors named "Vojtech Tretera"

Claim this Profile
P
Prognostic Biomarkers for Anti-PD-1 Monoclonal Antibodies in the First Line Treatment of Advanced Melanoma.
Marek Pásek, Emanuel Marques, Vojtěch Tretera, Petr Arenberger, Monika Arenbergerová

Int J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracorporeal photophoresis in treatment of corticosteroid refractory colitis induced by combined immunotherapy for metastatic melanoma.
Marek Pásek, Jindřich Kopecký, Vojtěch Tretera, Petr Arenberger, Monika Arenbergerová

J Eur Acad Dermatol Venereol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lichen Planus-Like Exanthema Induced by Anti-PD-1 and Anti-LAG-3 Combination Immunotherapy Could Potentially Predict the Treatment Response in Metastatic Melanoma.
Marek Pásek, Eva Sticová, Emanuel Marques, Vojtěch Tretera, Petr Arenberger

Dermatol Pract Concept· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The outcome in patients with BRAF-mutated metastatic melanoma treated with anti-programmed death receptor-1 monotherapy or targeted therapy in the real-world setting.
Jindřich Kopecký, Marek Pásek, Radek Lakomý, Bohuslav Melichar, Ivona Mrazová, Vojtěch Tretera

Cancer Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis